By serving large pharma and biotech companies worldwide for more than 15 years, SARomics Biostructures' team has established a proven track record of success and has gathered extensive experience in all aspects of structural biology. Each year on average we work with over 100 structural biology and early stage drug discovery projects.
Since 2006 more than 500 disclosable protein structures have been submitted to the PDB and our staff have contributed to more than 240 structural papers published in leading journals
like Nature, Nature Commun., Eur. J. Med. Chem., J. Biol. Chem, J. Synchrotron Rad., Sci. Rep., PNAS, J. Med. Chem., FASEB J., JACS, Biochemistry, etc. These are some of the most visible evidence for our achievements.